tradingkey.logo

AbbVie rises after Q4 earnings beat, upbeat forecast

ReutersFeb 4, 2026 1:02 PM

Shares of drugmaker AbbVie ABBV.N rise 1.09% to $228.13 premarket

Co reports Q4 adjusted profit of $2.71 per share vs. analysts' average estimate of $2.65, according to data compiled by LSEG

Expects FY 2026 adj. profit of $14.37 to $14.57 per share vs. analysts' average estimate of $14.24

Quarterly revenue of $16.62 billion beats analysts' average estimate of $16.42 billion

Shares rose ~29% in 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI